Feature | September 09, 2014

CT Lung Cancer Screening May Be More Helpful and Effective Than Previously Thought

CT Lung Cancer Screening May Be More Helpful and Effective Than Previously Thought

September 9, 2014 — Two new studies published online in the Journal of the American College of Radiology (JACR) indicate computed tomography (CT) lung cancer screening may benefit more people than previously thought and that the test can be made more effective by using the ACR Lung Imaging Reporting and Data System (Lung-RADS) to classify patient exams.

In “Experience With a CT Screening Program for Individuals at High Risk for Developing Lung Cancer,” McKee et al. examined retrospective data from Lahey Hospital & Medical Center in Burlington, Mass., to determine if patents with additional risk factors — outside of those recommended by the National Lung Screening Trial (NLST) criteria (group 1) — could benefit from annual lung CT screening. The NLST group 1 is the same group for which the United States Preventive Services Task Force (USPSTF) recommended CT lung cancer screening.

Meanwhile, the population in the National Comprehensive Cancer Network (NCCN) high-risk group 2 included those who were current and former smokers and quit for any length of time and had at least one lung cancer risk factor, excluding secondhand smoke exposure.

Over the study period, spanning from January 2012 through December 2013, the authors found similar lung cancer detection rates in both groups. “The annualized cancer detection rates for NCCN group 2 and group 1 were nearly identical at 1.8 percent and 1.6 percent, respectively,” the authors wrote. These findings suggest that expanding screening programs to include patients with additional risk factors has the potential to detect more cancers and save more lives.

Another study authored by McKee et al. assessed the effect of applying ACR Lung-RADS — a quality assurance tool to standardize lung cancer screening CT reporting and management recommendations, reduce confusion in lung cancer screening CT interpretations, and facilitate outcome monitoring — in a lung cancer screening program. In “Performance of ACR Lung-RADS in a Clinical CT Lung Screening Program,” the authors retroactively reclassified the CT exams of 2,180 patients who were identified as being at high risk for lung cancer using ACR Lung-RADS.

“ACR Lung-RADS increased the total positive predictive value (PPV) of the baseline CT lung screening examination by a factor of 2.5, in 1,603 patients from 6.9 percent to 17.3 percent,” the authors wrote. In addition, when applying ACR Lung-RADS, no false negatives were created and CT lung screening examinations positive for nonsolid nodules were virtually eliminated.

For more information: www.jacr.org

Related Content

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Sponsored Content | Case Study | Computed Tomography (CT) | November 06, 2018
The following is a summary of a study published in the
The NeuViz 16 Essence from Neusoft Medical Systems.

The NeuViz 16 Essence from Neusoft Medical Systems.

Feature | Computed Tomography (CT) | November 05, 2018 | By Melinda Taschetta-Millane
According to an industry mark...
Carestream Spotlights Healthcare IT and Imaging Systems at RSNA 2018
News | Information Technology | October 31, 2018
Carestream announced it will be displaying several imaging and healthcare information technology (IT) offerings at the...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Fujifilm Unveils FCT Embrace CT System for Oncology
Technology | Computed Tomography (CT) | October 23, 2018
Fujifilm Medical Systems U.S.A. Inc. recently introduced the FCT Embrace computed tomography (CT) system. Powered by...